Gideon Richter OJSC is one of the largest Eastern European pharmaceutical manufacturers. The company has mastered the production of 200 types of drugs, one fifth of which are its own unique developments.
Way to success
The first pharmacy "Gideon Richter" was launched in 1901 in Budapest, Hungary. At that time, pharmacists themselves prepared medicinal drugs. At the pharmacy, a laboratory was equipped where the release of organotherapeutic drugs produced from cattle gland extracts was organized.
After 6 years, the first plant was launched, production of lecithins, vitamins and other components was established. Later they mastered the processing of plant materials: digitalis preparations, derivatives of salicylic acid, appeared. By the way, the drug "Calmopyrine", developed in 1912, is used today. By 1914, Gideon Richter had patented 24 drugs, becoming a strategic pharmaceutical company in Austria-Hungary.
The pill that changed the world
With the beginning of the "era of contraception" in the 60s, many associate such a phenomenon as a significant change in the social status of women in society. Birth control pills allowed 100% to prevent an unplanned pregnancy.
It was the outstanding pharmacist from Budapest, Gideon Richter, who stood at the origins of hormonal synthesis and worked on the first contraceptive pill. The production of gynecological drugs was started from the very foundation of the company in 1901, together with the development of the first organotherapeutic drugs. In 1939, the company developed the technology for estrone release, and established industrial production of crystalline estrone. The creation of synthetic testosterone and progesterone has cemented its success.
Gideon Richter: drugs
In the 1950s, a key compound for hormone synthesis was created, used to produce sex hormones (progesterone, estrone, and testosterone), non-steroidal anabolic agents, and oral contraceptives.
Since the beginning of the 1960s, Gideon Richter began to use the most advanced production technologies, including sterile fermentation. In the future, thanks to new technologies, it became possible to manufacture new active substances, such as norgestrel, levonorgestrel and their derivatives, as a result of which a combined hormonal contraceptive was launched, released in 1966. The company also brought hormonal contraception to the USSR for the first time.
Now there are drugs of the fourth generation, which, for example, contain drospirenone as an active component. Being a synthetic hormone, it is similar to progesterone produced by the body.
Quality
Of paramount importance in the production of hormonal preparations are production control and compliance with all advanced standards. Simply put, it is important to understand how and under what technological conditions hormonal preparations are synthesized in order to speak boldly about the quality of the product and minimize undesirable effects. In the world, units of large concerns have their own synthesis of sex steroids. Armed with pharmaceutical production, high-performance liquid chromatography, nuclear magnetic resonance instruments and other high-tech assistants.
The substances for the manufacture of drugs and the hormonal components themselves are produced in Hungary, which allows us to trace all stages of production and be sure of the result. It is this quality and approach that doctors and patients trust, as well as scientists from those countries where the company supplies its famous substances.
Development
Today, the key factor in determining the weight of a company is intellectual capital, so leading companies need to invest in R&D (research and development). For the pharmaceutical business, this means that the core of development is research and development in the field of new product development and practical solutions. It is noteworthy that Gideon Richter is the only Eastern European company included in the TOP 200 in the category of innovation costs with an indicator of 12% of annual turnover.
In 2010, the joint-stock company bought the Swiss biopharmaceutical company Preglem. It offers molecules for the treatment of complex gynecological diseases such as uterine fibroids, endometriosis and others.
Gideon Richter-Rus
The company produces about two hundred kinds of medicines in more than 400 release forms. As part of the future strategy, it was decided in 1996 to create a separate production in Central Russia. Hungarian pharmacists built one of five subsidiaries in the Yegoryevsky district near Moscow. It produces:
- ready-made medications;
- intermediate compounds;
- active substances.
Thus, Gideon Richter-Rus became the first foreign pharmaceutical company in Russia. Today, the plant provides not only the domestic market, but also exports medicines to the CIS countries (Georgia, Armenia, Moldova, Azerbaijan).
For the good of society
The current situation involves the joint work of scientists - pharmacists and doctors for the benefit of society. Gideon Richter initiates and supports events of various levels in Russia:
- scientific and practical conferences;
- seminars, congresses;
- international forums.
The task of maintaining women's reproductive health must be addressed at all levels. Following this logic, Gideon Richter regularly carries out educational and other supporting activities for the professional community. For example, Hungarian pharmacists have sponsored the Russian Reproductive Tomorrow Award for many years. Prize winners make an invaluable contribution to the development of the Russian school of obstetrics and gynecology.
Gideon Richter has a scientific base at the highest world standards, its own scientific developments have allowed the company to significantly expand the range of gynecological drugs. A wide selection helps specialists and women make important decisions in their lives, while the qualitative and assortment composition of hormonal contraceptives continues to improve.